Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. (Q51755399)

11 April 2018

title

Diffuse sclerosing variant of papillary thyroid carcinoma: lack of BRAF mutation but occurrence of RET/PTC rearrangements. (English)

1 reference

11 April 2018

main subject

papillary thyroid cancer

1 reference

Sien-Yi Sheu

1

1 reference

11 April 2018

Suzan Schwertheim

2

1 reference

11 April 2018

Karl Worm

3

1 reference

11 April 2018

Florian Grabellus

4

1 reference

11 April 2018

Kurt Werner Schmid

5

1 reference

11 April 2018

publication date

27 April 2007

1 reference

11 April 2018

published in

Modern Pathology

1 reference

11 April 2018

volume

20

1 reference

11 April 2018

issue

7

1 reference

11 April 2018

page(s)

779-787

1 reference

11 April 2018

Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

A review of thyroid cancer with intermediate differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF mutation in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Alterations of the BRAF gene in thyroid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative diagnosis of papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF mutations in papillary carcinomas of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

RET/PTC rearrangement in thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine-rich country (Japan).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Diffuse sclerosing variant of papillary carcinoma of the thyroid. Clinical importance, surgical treatment, and follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Multiple brain metastases from a diffuse sclerosing variant of papillary carcinoma of the thyroid

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Diffuse sclerosing variant of papillary carcinoma of the thyroid: a 35-year comparative study at a single institution

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Molecular mechanisms of RET activation in human cancer.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Perspective: lessons learned from molecular genetic studies of thyroid cancer--insights into pathogenesis and tumor-specific therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

BRAF mutations in an Italian cohort of thyroid cancers.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

BRAF mutations are associated with some histological types of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Gene rearrangement and Chernobyl related thyroid cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

Correlation Between Genetic Alterations and Microscopic Features, Clinical Manifestations, and Prognostic Characteristics of Thyroid Papillary Carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800797

7 January 2021

10.1038/MODPATHOL.3800797

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018